WILCOX REED N 4

What Happened Reed N. Wilcox, a director of Clene Inc. (CLNN), was granted an option award for 3,306 shares on February 19, 2026. The grant was recorded as a derivative acquisition (no cash paid at grant). The options carry an exercise price of $4.73 per share (total exercise cost to buy all shares would be $15,637.38) and vest immediately upon grant.

Key Details

• Transaction date: February 19, 2026; Form 4 filed February 20, 2026 (timely filing).
• Transaction type: Option grant (derivative acquisition), 3,306 option shares, grant price $0.00 at issuance; exercise price $4.73/share (per filing footnote).
• Vesting: Options vest immediately upon grant (per footnote).
• Shares owned after transaction: Not specified in the summary details provided in the filing.
• Footnote: Award granted under the Clene Inc. Amended 2020 Stock Plan; immediate vesting noted.
• Filing status: No late filing indicated.

Context This was a grant of stock options (a derivative award), not a cash purchase or sale of existing shares. Immediate vesting means the options are exercisable right away, but the director would need to pay the $4.73 exercise price per share to convert options into common stock. Option grants are routine compensation for directors and do not, by themselves, indicate a buy or sell of shares on the open market.